CareCloud, Inc. CCLD
NASDAQ · United States · Technology Services
$2.05+0.00 (+0.25%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Experienced finance executive and CPA promoted as CareCloud scales its profitable, AI-powered healthcare technology platform; Norman Roth transitions from Interim CFO to Advisor to the CEO SOMERSET, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its Board of Directors has promoted Bonnie Boyer, MBA, CPA, from Assistant Chief Financial
Bilbel Capital, an investment management company, released its second-quarter 2026 investment letter. The letter can be downloaded here. The strategy returned -15.7%, gross and -16.1%, net, in the first half of 2026, compared to a 10.2% return for the S&P 500 Index. The letter outlines top positions, all acquired under 3.5 times a normal year’s […]
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
KabaFusion partners with CareCloud to develop a fully integrated application, powered by artificial intelligence, designed for the home infusion workflow Somerset, NJ and Lexington, MA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- KabaFusion, one of the nation's largest providers of home infusion therapy, and CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in healthcare technology, today announced a partnership to build LailaCare, a platform powered by artificial intelligence and de
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.